Cancer Genetics launches Solid Tumor Hotspot Panel for Biopharma and Clinical customers throughout Asia
Cancer Genetics announced that Cancer Genetics India (CG India) has launched a Next-Generation Sequencing (NGS) based panel targeting the five most common solid tumors: breast, colorectal, lung, skin, and ovarian…